Hameed, S. Et Al. 2024. Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity. International Journal of Biological Macromolecules , vol.263 .

Hameed, S., Saleem, F., Özil, M., Baltaş, N., Salar, U., Ashraf, S., ... Ul-Haq, Z.(2024). Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity. International Journal of Biological Macromolecules , vol.263.

Hameed, Shehryar Et Al. "Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity," International Journal of Biological Macromolecules , vol.263, 2024

Hameed, Shehryar Et Al. "Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity." International Journal of Biological Macromolecules , vol.263, 2024

Hameed, S. Et Al. (2024) . "Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity." International Journal of Biological Macromolecules , vol.263.

@article{article, author={Shehryar Hameed Et Al. }, title={Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity}, journal={International Journal of Biological Macromolecules}, year=2024}